AI
CRL icon

Analytic Investors’s Charles River Laboratories CRL Stock Holding History

Analytic Investors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12,795
Closed -$1.05M – 609
2016
Q2 		$1.05M Buy
+12,795
New +$1.05M 0.01% 373
2014
Q4 		– Sell
-26,306
Closed -$1.57M – 548
2014
Q3 		$1.57M Buy
26,306
+3,387
+15% +$194K 0.02% 300
2014
Q2 		$1.23M Buy
22,919
+956
+4% +$52.5K 0.02% 295
2014
Q1 		$1.32M Sell
21,963
-191
-0.9% -$11.1K 0.02% 330
2013
Q4 		$1.18M Sell
22,154
-15,787
-42% -$793K 0.02% 298
2013
Q3 		$1.75M Sell
37,941
-14,560
-28% -$668K 0.03% 247
2013
Q2 		$2.15M Buy
+52,501
New +$2.25M 0.04% 269

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Analytic Investors's CRL Position: Q3 2016 in Review

Analytic Investors sold out of Charles River Laboratories (CRL) in Q3 2016, closing a stake of 12,795 shares — an estimated $1.05M sold.

Analytic Investors first reported a position in CRL in Q2 2013 and held it in 7 quarters. The position peaked at $2.15M in Q2 2013. 283 funds tracked by Wall St. Rank hold CRL as of Q3 2016.

  • Analytic Investors reported no remaining Charles River Laboratories position as of Q3 2016 after selling out during the quarter.
  • Analytic Investors sold 12,795 Charles River Laboratories shares in Q3 2016, an estimated $1.05M.
  • Analytic Investors first reported a position in Charles River Laboratories in Q2 2013 and held it in 7 quarters.
  • Analytic Investors's Charles River Laboratories position peaked at $2.15M in Q2 2013.
  • 283 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.